CLMT
カルメット
CLMT
カルメット
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Calumet, Inc. ("Calumet" or the "Company") (NASDAQ: CLMT). Such investors are advised to contac
Calumet, Inc. (CLMT) Q2 2026 Earnings Call Transcript